[JM Test] PROVIDING INNOVATIVE AND EFFECTIVE SOLUTIONS FOR TOOTH SENSITIVITY: GSK’s Successful Launch of Sensodyne Repair and Protect Deep Repair
25 Jul 2024
byJenny Ng
In its push to continue to
innovate and provide timely, relevant, and high-quality products for its
consumers, and in line with the goal of helping healthcare partners to deliver
quality healthcare, GSK has recently launched its newest addition to their product
line-up – Sensodyne Repair and Protect Deep Repair.
In the recently held live online event, attended by dental practitioners nationwide, GSK has brought together esteemed speakers and renowned oral health care experts in the persons of Dr Angelo Militante, president of the Philippine Dental Association and of the Philippine College of Oral and Maxillofacial Surgeons; as well as Dr Leo De Castro, past president of Philippine Dental Association, the Philippine Academy of Implant Dentistry, and the Makati Dental Society. They were joined by Mr Jeff Go, the General Manager of GSK Consumer Healthcare Philippines and Ms Enid Moraa, GSK’s Area Expert Marketing Manager (Southeast Asia and Taiwan). The event was hosted by Ms Ayie Tinsay, a prominent social media figure.
During their dynamic discussion, the speakers initially explored the effect of the pandemic and how it has brought about the shift to home oral care in lieu of actual dental visits. They also tackled the role of dentists in home oral health care, the importance of patient education, and the value of GSK’s continued partnership with dentists and dental societies in addressing the needs of patients, especially those with sensitive teeth.
Further adding value to the discussion, Dr Charlie Parkinson, GSK’s Medical Affairs Director on Oral Health delivered an expert lecture on the topic of dentine hypersensitivity and the latest strategies in its management. In his lecture, Dr Parkinson highlighted the psychosocial impact of dentine hypersensitivity and the existing oral care products available to consumers, among which are occlusion agents. He also explained in detail how Novamin, the occlusion agent present in Sensodyne Repair and Protect Deep Repair, triggers a cascade of events upon contact with saliva, which results to the formation of a hydroxyapatite-like layer over and within exposed dentine tubules, effectively addressing the core of the problem in patients with sensitive teeth, and thereby providing lasting protection and relief. The panel of speakers also addressed queries from the attendees during the open forum segment following the expert lecture.
In wrapping up the event, Mr Jeff Go expressed Sensodyne and GSK’s commitment to their advocacy in ensuring accessibility of effective and high-quality oral health care. Likewise, Dr Angelo Militante and Dr Leo De Castro conveyed their commitment to providing quality oral health care services and being champions of patient education.
Indeed, the COVID-19 pandemic has proven to be an effective catalyst for change. And with the successful launch of their new product line-up, GSK has once again proven themselves as a reliable healthcare partner responsive to the community and patient’s needs. GSK and Sensodyne continues to search for opportunities to innovate and empower consumers and healthcare providers to adapt to the new realities brought about by COVID-19.
In the recently held live online event, attended by dental practitioners nationwide, GSK has brought together esteemed speakers and renowned oral health care experts in the persons of Dr Angelo Militante, president of the Philippine Dental Association and of the Philippine College of Oral and Maxillofacial Surgeons; as well as Dr Leo De Castro, past president of Philippine Dental Association, the Philippine Academy of Implant Dentistry, and the Makati Dental Society. They were joined by Mr Jeff Go, the General Manager of GSK Consumer Healthcare Philippines and Ms Enid Moraa, GSK’s Area Expert Marketing Manager (Southeast Asia and Taiwan). The event was hosted by Ms Ayie Tinsay, a prominent social media figure.
During their dynamic discussion, the speakers initially explored the effect of the pandemic and how it has brought about the shift to home oral care in lieu of actual dental visits. They also tackled the role of dentists in home oral health care, the importance of patient education, and the value of GSK’s continued partnership with dentists and dental societies in addressing the needs of patients, especially those with sensitive teeth.
Further adding value to the discussion, Dr Charlie Parkinson, GSK’s Medical Affairs Director on Oral Health delivered an expert lecture on the topic of dentine hypersensitivity and the latest strategies in its management. In his lecture, Dr Parkinson highlighted the psychosocial impact of dentine hypersensitivity and the existing oral care products available to consumers, among which are occlusion agents. He also explained in detail how Novamin, the occlusion agent present in Sensodyne Repair and Protect Deep Repair, triggers a cascade of events upon contact with saliva, which results to the formation of a hydroxyapatite-like layer over and within exposed dentine tubules, effectively addressing the core of the problem in patients with sensitive teeth, and thereby providing lasting protection and relief. The panel of speakers also addressed queries from the attendees during the open forum segment following the expert lecture.
In wrapping up the event, Mr Jeff Go expressed Sensodyne and GSK’s commitment to their advocacy in ensuring accessibility of effective and high-quality oral health care. Likewise, Dr Angelo Militante and Dr Leo De Castro conveyed their commitment to providing quality oral health care services and being champions of patient education.
Indeed, the COVID-19 pandemic has proven to be an effective catalyst for change. And with the successful launch of their new product line-up, GSK has once again proven themselves as a reliable healthcare partner responsive to the community and patient’s needs. GSK and Sensodyne continues to search for opportunities to innovate and empower consumers and healthcare providers to adapt to the new realities brought about by COVID-19.